Seizure control and side-effect profile after switching adult epileptic patients from standard to extended-release divalproex sodium.

作者: Serge J.C. Pierre-Louis , Richard T. Brannegan , Arthur T. Evans

DOI: 10.1016/J.CLINEURO.2008.12.009

关键词:

摘要: Objectives: To assess changes in seizure frequency, medication side-effects (especially tremor) and formulation preference after switching patients overnight from immediate-release to extended-release divalproex sodium. Methods: Prospective evaluation of consecutive adult outpatients at an urban public hospital who were followed for 6 months drug formulations. Seizure frequency was estimated patient self-reports. Medication monitored with a structured interview (tremor, fatigue, GI upset, hair loss), physician exam (nystagmus, tremor), drawing test (tremor) specific 25-item questionnaire assessing the impact tremor on activities daily living. Results: Forty-seven included study but six either lost follow-up or had insufficient data. side-effect profile did not change significantly However, significant subjective improvement their as assessed by (p = 0.009 3 p 0.04 months); other measures severity showed no during 6-month period. Most (71%) preferred formulation. Conclusion: Patients epilepsy can be switched standard sodium, without profile. prefer formulation, part due decrease activities.

参考文章(17)
Sandeep Dutta, Ronald C. Reed, John H. Cavanaugh, Absolute Bioavailability and Absorption Characteristics of Divalproex Sodium Extended-Release Tablets in Healthy Volunteers The Journal of Clinical Pharmacology. ,vol. 44, pp. 737- 742 ,(2004) , 10.1177/0091270004266782
M Vidailhet, C D Marsden, P G Bain, P Atchison, M Behari, P D Thompson, M Gresty, J C Rothwell, L J Findley, Assessing Tremor Severity ,(1993)
Ronald C. Reed, Sandeep Dutta, John H. Cavanaugh, Charles Locke, G. Richard Granneman, Every-12-hour administration of extended-release divalproex in patients with epilepsy: Impact on plasma valproic acid concentrations Epilepsy & Behavior. ,vol. 8, pp. 391- 396 ,(2006) , 10.1016/J.YEBEH.2005.12.004
Joyce A. Cramer, How Often Is Medication Taken as Prescribed? JAMA. ,vol. 261, pp. 3273- 3277 ,(1989) , 10.1001/JAMA.1989.03420220087032
Lydia Kernitsky, Kathryn A. O'Hara, Ping Jiang, John M. Pellock, Extended-release divalproex in child and adolescent outpatients with epilepsy. Epilepsia. ,vol. 46, pp. 440- 443 ,(2005) , 10.1111/J.0013-9580.2005.39804.X
Paul H. McCabe, Nancy C. Michel, Cathy D. McNew, Erik B. Lehman, Conversion from delayed-release sodium valproate to extended-release sodium valproate: Initial results and long-term follow-up Epilepsy & Behavior. ,vol. 8, pp. 601- 605 ,(2006) , 10.1016/J.YEBEH.2006.02.006
Sandeep Dutta, Yiming Zhang, Daniel S. Selness, Lillian L. Lee, Laura A. Williams, Kenneth W. Sommerville, Comparison of the bioavailability of unequal doses of divalproex sodium extended-release formulation relative to the delayed-release formulation in healthy volunteers. Epilepsy Research. ,vol. 49, pp. 1- 10 ,(2002) , 10.1016/S0920-1211(02)00007-4
R.de Wit, F.S.A.M.van Dam, A.van Buuren, C.van der Heijden, How often is medication taken as prescribed? European Journal of Cancer. ,vol. 29, pp. S260- ,(1993) , 10.1016/0959-8049(93)92083-5
Manon Thibault, Warren T Blume, Jean-Marc Saint-Hilaire, Rafik Zakhari, Kenneth W Sommerville, Divalproex extended-release versus the original divalproex tablet: results of a randomized, crossover study of well-controlled epileptic patients with primary generalized seizures. Epilepsy Research. ,vol. 50, pp. 243- 249 ,(2002) , 10.1016/S0920-1211(02)00048-7